ImmunityBio (IBRX) Return on Capital Employed (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 544.00 |
| Dec 31, 2025 | 758.00 |
| Sep 30, 2025 | 2,977.00 |
| Jun 30, 2025 | 1,215.00 |
| Mar 31, 2025 | 141.00 |
| Dec 31, 2024 | -310.00 |
| Sep 30, 2024 | -495.00 |
| Jun 30, 2024 | -1,318.00 |
| Mar 31, 2024 | 160.00 |
| Dec 31, 2023 | 4,492.00 |
| Sep 30, 2023 | -25,900.00 |
| Jun 30, 2023 | -4,726.00 |
| Mar 31, 2023 | -7,229.00 |
| Dec 31, 2022 | 37,599.00 |
| Sep 30, 2022 | -162,058.00 |
| Jun 30, 2022 | 219,475.00 |
| Mar 31, 2022 | -191,338.00 |
| Dec 31, 2021 | 137,940.00 |
| Sep 30, 2021 | 438.00 |
| Jun 30, 2021 | -267.00 |
| Mar 31, 2021 | -3,378.00 |
| Dec 31, 2020 | -3,767.00 |
| Sep 30, 2020 | -1,827.00 |
| Jun 30, 2020 | -1,156.00 |
| Mar 31, 2020 | -2,292.00 |
| Dec 31, 2019 | -374.00 |
| Sep 30, 2019 | -152.00 |
| Jun 30, 2019 | 969.00 |
| Mar 31, 2019 | 697.00 |
| Dec 31, 2018 | 42.00 |
| Sep 30, 2018 | -714.00 |
| Jun 30, 2018 | -690.00 |
| Mar 31, 2018 | -543.00 |
| Dec 31, 2017 | -287.00 |
| Sep 30, 2017 | 246.00 |
| Jun 30, 2017 | -41.00 |
| Mar 31, 2017 | -8.00 |
| Dec 31, 2016 | -37.00 |
| Sep 30, 2016 | 255.00 |
| Jun 30, 2016 | 2,526.00 |
| Mar 31, 2016 | -162.00 |
| Dec 31, 2015 | 2,032.00 |